FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet

Kernel’s Brain-Imag­ing Hel­met Approved For Clin­i­cal Tri­al On Patients Using Ket­a­mine (Forbes): The U.S. Food and Drug Admin­is­tra­tion has approved a clin­i­cal tri­al using a neu­roimag­ing hel­met made by Los Ange­les-based Ker­nel to track what hap­pens in the brain when a human takes a psy­che­del­ic dose of ketamine.

Read More

Michael Merzenich on Brain Training, Assessments, and Personal Brain Trainers

Inter­view with Dr. Michael Merzenich, Emer­i­tus Pro­fes­sor at UCSF, a lead­ing pio­neer in brain plas­tic­i­ty research. In the late 1980s, Dr. Merzenich was on the team that invent­ed the cochlear implant. In 1996, he was the found­ing CEO of Sci­en­tif­ic Learn­ing Cor­po­ra­tion (Nas­daq: SCIL), and in 2004 became co-founder and Chief Sci­en­tif­ic Offi­cer of Posit Sci­ence. He was elect­ed to the Nation­al Acad­e­my of Sci­ences in 1999 and to the Insti­tute of Med­i­cine this year. He retired as Fran­cis A. Sooy Pro­fes­sor and Co-Direc­tor of the Keck Cen­ter for Inte­gra­tive Neu­ro­science at the Uni­ver­si­ty of Cal­i­for­nia at San Fran­cis­co in 2007. You may have learned about his work in one of PBS TV spe­cials, mul­ti­ple media appear­ances, or neu­ro­plas­tic­i­ty-relat­ed books.

Read More